DocGo appoints Dr. Stephen K. Klasko as independent Chair; Steven Katz resigns

DocGo Inc.

Dr. Klasko appointed Class III director and independent Chair of Board effective October 1, 2024.
He previously led Jefferson Health (18 hospitals, 35K employees) and is a Special Advisor at General Catalyst.
Steven Katz resigned as Chair and director; will consult through Dec 31, 2024, at $2,500/month plus $400/hour over 5 hours.
Dr. Klasko receives $500K one-time stock option grant (1-year vest) and $300K cash compensation for first year as Chair.
Katz's departure was not due to any disagreement with the Company.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steven Katz

Chair of the Board

DCGO · DocGo Inc.

Effective: 2024-10-01
Successor: Stephen K. Klasko
Filed: September 30, 2024, 7:59 PM ET

On September 25, 2024, Mr. Katz notified the Board that he intends to step down as a director and Chair of the Board, effective as of the Effective Date.

Appointed

Stephen K. Klasko

Independent Chair of the Board

DCGO · DocGo Inc.

Effective: 2024-10-01
Filed: September 30, 2024, 7:59 PM ET

On September 26, 2024, the Board of Directors (the “Board”) of DocGo Inc. (the “Company”) appointed Stephen K. Klasko, MD as a Class III director and independent Chair of the Board, effective as of October 1, 2024 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Katz resigned as Chair of the Board at DocGo Inc..

Action: resigned
Role: Chair of the Board

Exact text from the filing

On September 25, 2024, Mr. Katz notified the Board that he intends to step down as a director and Chair of the Board, effective as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen K. Klasko was appointed as Independent Chair of the Board at DocGo Inc..

Action: appointed
Role: Independent Chair of the Board

Exact text from the filing

On September 26, 2024, the Board of Directors (the “Board”) of DocGo Inc. (the “Company”) appointed Stephen K. Klasko, MD as a Class III director and independent Chair of the Board, effective as of October 1, 2024 (the “Effective Date”).

View on SEC.gov

DocGo Inc. filing history →

Source: SEC EDGAR

accession 0001822359-24-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.